Inventi Impact: Biosimilars & Biopharmaceuticals

Articles

Inventi:pbs/27794/18

A Randomized Controlled Trial Comparing PF-06438179/GP1111 (An Infliximab Biosimilar) and\nInfliximab Reference Product for Treatment of Moderate to Severe Active Rheumatoid Arthritis\nDespite Methotrexate Therapy

Research 2019 : January - March

Stanley B Cohen, Rieke Alten, Hideto Kameda, Tomas Hala, Sebastiao C Radominski, Muhammad I Rehman, Ramesh Palaparthy, Karl Schumacher, Susanne Schmitt, Steven Y Hua, Claudia Ianos, K Lea Sewell

notavailable

How to Cite this Article
Cohen, Stanley B., et al. \"A randomized\ncontrolled trial comparing PF-06438179/GP1111 (an\ninfliximab biosimilar) and infliximab reference product for\ntreatment of moderate to severe active rheumatoid arthritis\ndespite methotrexate therapy.\" Arthritis research & therapy\n20.1 (2018): 155, https://doi.org/10.1186/\ns13075-018-1646-4, http://creativecommons.org/licenses/\nby/4.0/.
Download Full Text

(+91) 89626 12340
[email protected]
Inventi Journals Pvt. Ltd.
SDX 82, Minal Residency, JK Road,
BHOPAL, 462023, MP, India